Binding studies of L-prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brain.
D000978:Antiparkinson Agents / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D009075:MSH Release-Inhibiting Hormone / Q000378:metabolism*; D008566:Membranes / Q000378:metabolism; D017981:Receptors, Neurotransmitter / Q000187:drug effects
D000978:Antiparkinson Agents; D017981:Receptors, Neurotransmitter; D009075:MSH Release-Inhibiting Hormone